$NLNK LUMOS PHARMA, INC. Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in LUMOS PHARMA, INC..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in LUMOS PHARMA, INC.. Insider overview, share value development, latest insider transactions and email notifications about new events in LUMOS PHARMA, INC. for free.

CIK Number: 0001126234
IRS Number: 421491350
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: NLNK
Company Address: 4200 MARATHON BLVD. SUITE 200 AUSTIN 78756
Phone number: 515-296-5555
Former name: NEWLINK GENETICS CORP, date of change: 2000-10-12

Market Capitalization: $408.17M
Prev close: $13.67
Average Daily Volume: 258,305
Days Low: $13.17
Year Low: $9.23
Year High: $26.49

LUMOS PHARMA, INC. Insiders Active In Last 3 Months

NamePositionTotal SharesCurrent Value ($)Last 3 MonthsBuy / SellLast Transaction
Hawkins Richard JChief Executive Officer745,38210,189,372shares bought: 25,000 / shares sold: -1,522 BUYApr 05 20211 month ago
Langren Carl W.Chief Financial Officer11,494157,123shares bought: 21,087 / shares sold: -8,276 STRONG BUYApr 05 20211 month ago
Lawley Lori DPrincipal Accounting Officer5,43774,324shares bought: 4,500 / shares sold: -274 BUYApr 05 20211 month ago
McKew John C.Chief Scientific Officer13,226180,799shares bought: 13,000 / shares sold: -1,036 BUYApr 05 20211 month ago
POWERS BRADLEY JGeneral Counsel5,08269,471shares bought: 4,500 / shares sold: -418 BUYApr 05 20211 month ago

View all LUMOS PHARMA, INC. insiders.

LUMOS PHARMA, INC. Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Apr 05 2021NLNKLUMOS PHARMA, INC.POWERS BRADLEY JGeneral CounselPayment of ExerciseF12.253424,1905,0825.4 K to 5.1 K (-6.31 %)
Apr 05 2021NLNKLUMOS PHARMA, INC.McKew John C.Chief Scientific Of ...Payment of ExerciseF12.251,03612,69113,22614.3 K to 13.2 K (-7.26 %)
Apr 05 2021NLNKLUMOS PHARMA, INC.Lawley Lori DPrincipal Accountin ...Payment of ExerciseF12.252743,3575,4375.7 K to 5.4 K (-4.80 %)
Apr 05 2021NLNKLUMOS PHARMA, INC.Langren Carl W.Chief Financial Off ...Payment of ExerciseF12.256838,36711,49412.2 K to 11.5 K (-5.61 %)
Apr 05 2021NLNKLUMOS PHARMA, INC.Hawkins Richard JChief Executive Off ...Payment of ExerciseF12.251,52218,645745,382746.9 K to 745.4 K (-0.20 %)
Jan 08 2021NLNKLUMOS PHARMA, INC.Flynn James E10% OwnerSellS22.24101,6002,259,797784,568886.2 K to 784.6 K (-11.47 %)
Jan 08 2021NLNKLUMOS PHARMA, INC.Flynn James E10% OwnerSellS23.573,91292,194886,168890.1 K to 886.2 K (-0.44 %)
Jan 08 2021NLNKLUMOS PHARMA, INC.Flynn James E10% OwnerSellS24.111,00024,108890,080891.1 K to 890.1 K (-0.11 %)
Jan 08 2021NLNKLUMOS PHARMA, INC.Flynn James E10% OwnerSellS25.054,378109,665891,080895.5 K to 891.1 K (-0.49 %)
Jan 08 2021NLNKLUMOS PHARMA, INC.Flynn James E10% OwnerSellS24.3511,794287,157895,458907.3 K to 895.5 K (-1.30 %)
Jan 08 2021NLNKLUMOS PHARMA, INC.Flynn James E10% OwnerSellS22.6493121,082907,252908.2 K to 907.3 K (-0.10 %)
Jan 08 2021NLNKLUMOS PHARMA, INC.Flynn James E10% OwnerSellS22.4728,108631,620908,183936.3 K to 908.2 K (-3.00 %)
Apr 07 2020NLNKLUMOS PHARMA, INC.Zoth Lota S.DirectorOption ExerciseA7.785,68444,2225,684
Apr 07 2020NLNKLUMOS PHARMA, INC.Zoth Lota S.DirectorGrantA0.0070901,8201.1 K to 1.8 K (+63.82 %)
Apr 07 2020NLNKLUMOS PHARMA, INC.Raffin Thomas A.DirectorOption ExerciseA7.785,68444,2225,684

View all LUMOS PHARMA, INC. insider transactions.